Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Cigna's Acquisitions, Diversified Businesses to Aid Growth

By Zacks Investment ResearchStock MarketsOct 06, 2020 01:23AM ET
www.investing.com/analysis/cignas-acquisitions-diversified-businesses-to-aid-growth-200540124
Cigna's Acquisitions, Diversified Businesses to Aid Growth
By Zacks Investment Research   |  Oct 06, 2020 01:23AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

Cigna Corp. CI seems well-poised for growth on the back of its vast and diversified business profile, a solid balance sheet and a strong operating performance.

Company’s strong business profile:

Acquisition of Express Scripts (NASDAQ:ESRX): This deal made the company a one-stop shop for customers' healthcare needs, ranging from the sale of its drugs to insurance cover, providing it with the benefits of a vertical integration. The combined company rose through the ranks in the health insurance industry, strengthening its competitive edge.

Other Buyouts: The company in the first quarter of 2019 acquired OnePath Life Insurance from ANZ Bank in New Zealand. This acquisition enabled the company to delve deeper into an existing geography with an expanded set of solutions and capabilities to create more value for its customers, intensify its continued focus on effective capital deployment and drive long-term growth. This will also grow its international operations, which have been aiding revenues over the years.

Increasing Top Line: The company’s revenues have been bumping up consistently since the last several years. The same was up 14.4% in the first six months of 2020 owing to the acquisition of Express Scripts. For 2020, the company expects consolidated adjusted revenues in the range of $154-$156 billion, representing 10-11% growth.

Improving Bottom Line: Along with top-line growth, Cigna has been able to maintain bottom-line profitability, evident from its annual earnings growth since 2009 (except in 2016 when earnings per share declined 6.4%). Its EPS witnessed a CAGR of 17% from 2014 to 2019. This operating profitability has been maintained so far by controlled medical care cost and other operating costs. In the first six months of 2020, the company’s bottom line grew 28% year over year. For 2020, consolidated adjusted income from operations is expected to be $6.8-$7 billion or $18-$18.60 per share. This suggests growth in the 9-13% band from 2019 baseline earnings. For 2021, the company targets an EPS of $20-$21.

Cigna to Divest Non-Health Unit: The company announced that it will sell its non-health insurance unit Group Life and Disability insurance business to New York Life, America’s largest mutual life insurer. The sale valued at $6.3 billion is expected to fetch $5.3 billion. This strategic move is in line with the company’s efforts to reduce its debt level, which increased after the buyout of Express Scripts last year.

Growing Membership: Cigna has been extending its membership for the past many quarters. We expect a rise in membership going forward, given the company’s diversified product portfolio, a wide agent network and superior service, which should drive enrollment in the Commercial market segments.

Favorable Cash Flows: The company has been generating positive cash flow from operations over the past several years. This reflects its healthy business operations. In the first six months of 2020, cash flow from operations ascended 22% year over year to $5.2 billion. Consistent cash flow generation enables the company to reinvest in its business, go for strategic mergers and acquisitions and return capital to its shareholders via dividend payments and share buybacks.

Year to date, the stock has lost 15.7% against its industry’s growth of 0.4%.


However, other companies in the same space, namely UnitedHealth Group Inc. UNH and Humana Inc (NYSE:HUM). HUM have gained 8.3% and 14.6%, respectively, but Anthem Inc. ANTM has been down 5.2% over the same time period.

The decline in share price of Cigna makes the stock attractively priced. Its price-to-earnings ratio (forward-12 month) of 8.26 is lower than the industry average of 15.71 and is also below the 5-year median of 13.25.

The stock currently has a Zacks Rank #2 (Buy) and a Value Score of A. Back-tested results show that stocks with a Value Score of A or B combined with a Zacks Rank #1 (Strong Buy) or 2 are the best investment bets. You can see the complete list of today’s Zacks #1 Rank stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>




Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

UnitedHealth Group Incorporated (NYSE:UNH): Free Stock Analysis Report

Humana Inc. (HUM): Free Stock Analysis Report

Cigna Corporation (NYSE:CI): Free Stock Analysis Report

Anthem, Inc. (ANTM): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research
Cigna's Acquisitions, Diversified Businesses to Aid Growth
 

Related Articles

Declan Fallon
Russell 2000 Set Up For Breakout By Declan Fallon - Jun 14, 2021 3

Friday didn't offer a whole lot for Large Caps or Tech Indices; volume was down and the net position for the indices was unchanged.  The NASDAQ was caught below internal base...

Al Brooks
E-mini: Weak Follow-Through After Breakout By Al Brooks - Jun 14, 2021

E-mini pre-open market analysis - daily chartThursday saw the E-mini close above the May 7 high, which was the Breakout Point at the top of a 2-month trading range. On Friday, it...

Cigna's Acquisitions, Diversified Businesses to Aid Growth

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email